Publication: Fournier's Gangrene: Microbiological Profile and Risk Factors for Mortality: Review of 97 Cases
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Objective:Fournier's gangrene (FG) is a rare necrotizing fasciitis affecting genital and peri-anal areas. This study aimed to provide data on predicting factors, mortality rates, and factors affecting mortality in comparison of survivors and non-survivors in patients with FG. Materials and Methods:This study included a retrospective analysis of patients diagnosed with FG between 2008 and 2018. Results:A total of 97 patients with FG were included in this study. Of the patients, 72 (74%) were male. The mean age was 56.03 +/- 13.92 years, and the median was 57 (21-90). The mortality rate was 21.6%. The most frequently isolated microorganism from tissue and blood cultures was Escherichia coli (43%-42%). The median Fournier's Gangrene Severity Index (FGSI) and Uludag FGSI (UFGSI) scores were 4 (0-20) and 5 (1-22), respectively. In the univar-iate model, mortality risk increases 7.18 times (p=0.001) in patients with two or more co -morbidities, 1.31 times as the FGSI score increases (p<0.001), 1.28 times as the UFGSI score increases (p<0.001). When the cut-off value was set as 8 for the FGSI score, the sensitivity was 71.43%, and the specificity was 73.68%. The sensitivity was 73.43%, and the specificity was 75% when the cut-off value was set as 6 for the UFGSI score. In the univariate model, the mortality risk of those with hypotension was 6.07 times higher (p=0.003); as the platelet count increased, mortality risk decreased (odds ratio [OR]=0.99; p=0.02). The mortality risk of those hospitalized in the intensive care unit (ICU) was 16.5 times higher than those followed in the ward (p<0.001). In the multivariate model, this ratio was 6.49. Conclusion:We concluded that FGSI and UFGSI scores could be used to predict mortality. Management of FG requires a multidisciplinary approach. Empiric treatment should include carbapenems and be de-escalated once getting the culture results. Authors from different centers should report their experiences to help reveal the ideal treatment and evaluate the consequences.
Description
Atilla, Aynur/0000-0001-8027-1991; Kuruoglu, Tuba/0000-0003-3805-367X; Kamali Polat, Ayfer/0000-0001-6414-9435
Keywords
Citation
WoS Q
Scopus Q
Source
Infectious Diseases and Clinical Microbiology
Volume
5
Issue
1
Start Page
13
End Page
22
